| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $12.86 ▲ +1.50% | wingi | $12.59 ▼ -0.63% | Sesuk Generate Biomedicines Inc. Common Stock (GENB) persiyapan wis anchored kanggo $12.67 lan target $12.86 (+1.50%). Waca sing cedhak yaiku munggah; nonton $13.05 / $12.29 amarga volatilitas sing diwujudake saben dina babagan 7.75%. |
Sesuk Generate Biomedicines Inc. Common Stock (GENB) persiyapan wis anchored kanggo $12.67 lan target $12.86 (+1.50%). Waca sing cedhak yaiku munggah; nonton $13.05 / $12.29 amarga volatilitas sing diwujudake saben dina babagan 7.75%. | ||||
| Minggu | $13.26 ▲ +4.67% | Minggu kepungkur | $12.42 ▼ -1.96% | Model 7 dina Generate Biomedicines Inc. Common Stock pindhah saka $12.42 menyang $13.26 (+4.67%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $13.05 / $12.29 prakara luwih saka siji obah. |
Model 7 dina Generate Biomedicines Inc. Common Stock pindhah saka $12.42 menyang $13.26 (+4.67%). Iku menehi konteks momentum munggah kanggo saham iki, supaya break watara $13.05 / $12.29 prakara luwih saka siji obah. | ||||
| wulan | $13.93 ▲ +9.96% | Wulan kepungkur | $12.14 ▼ -4.18% | Target 1 wulan Generate Biomedicines Inc. Common Stock yaiku $13.93 (+9.96%), dibandhingake karo referensi langsung ing cedhak $12.67. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Generate Biomedicines Inc. Common Stock yaiku $13.93 (+9.96%), dibandhingake karo referensi langsung ing cedhak $12.67. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $14.93 ▲ +17.87% | Taun kepungkur | $11.72 ▼ -7.51% | Skenario 1 taun Generate Biomedicines Inc. Common Stock nuduhake $14.93 (+17.87%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Generate Biomedicines Inc. Common Stock nuduhake $14.93 (+17.87%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $17.29 ▲ +36.43% | 5 Taun kepungkur | $10.73 ▼ -15.30% | Tampilan 5 taun Generate Biomedicines Inc. Common Stock yaiku $17.29 (+36.43%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Generate Biomedicines Inc. Common Stock yaiku $17.29 (+36.43%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $12.67 | agêng |
| Ganti saben dina | +4.54% | Ndhuwur |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 67% | Ndhuwur |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $12.67 | Ganti saben dina | +4.54% |
| Pasar Kab | $1.61B | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.